Aggressively reduced radiation therapy for HPV-related throat cancer achieves similar control rates with fewer side effects

Monday, September 25, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Phase II trial indicates viability of half the standard dose for appropriately selected patients with oropharynx cancer following surgery



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook